The downstream target proteins of NRF2, such as glutathione peroxidase 4, ferritin heavy chain 1, and glucose-6-phosphate dehydrogenase, showed comparable outcomes to NRF2 protein, leading to ferroptosis in tiliroside-treated HCC cells. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.